Sera Prognostics inks deal with MultiPlan for pregnancy test

LabPulse.com staff writers
Jan 31, 2022
2022 02 01 23 05 7997 Business Contract Signing 400

Sera Prognostics has signed an agreement with MultiPlan to add its PreTRM pregnancy biomarker blood test to MultiPlan's private healthcare system (PHCS) and MultiPlan Networks.

As a result of the deal, more than 700 healthcare payers and 1.2 million healthcare providers participating in MultiPlan's provider networks will be able to order PreTRM Test, a proteomic blood test for measuring a woman's risk of spontaneous preterm birth.
Latest in Agreement
Business Agreement Social
Patient Square Capital to acquire NanoString assets for $220M
March 11, 2024
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
T Cell Social
Astellas snags chance to license Poseida cell therapy in $50M deal
August 9, 2023
Business Men Handshake Social
Guardant and Illumina resolve lawsuit, reach agreement
August 7, 2023
Related Stories
Blood Test Samples Lab Social
Collaboration
Blood test could improve detection of potentially fatal pregnancy complication: study
Hospital Baby Nurse Social
Preterm Birth
Fors Marsh to offer Sera Prognostics preterm birth risk test to employees
Teething Baby Doctor Social
Collaboration
Biora Therapeutics, Avero Diagnostics to develop preeclampsia rule-out test
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Agreement
Patient Square Capital to acquire NanoString assets for $220M
By LabPulse.com staff writers
NanoString Technologies has reached a binding agreement with Patient Square Capital in which NanoString will sell substantially all of its assets to the investment firm for $220 million.
March 11, 2024
Business Agreement Social
Flatiron Health, Guardant Health to integrate tests, EMR platform
By LabPulse.com staff writers
Flatiron Health and Guardant Health have signed an agreement to integrate Guardant’s genomic profiling test portfolio into Flatiron’s cloud-based OncoEMR electronic medical record (EMR) platform.
November 1, 2023
Business Agreement Social
Astellas snags chance to license Poseida cell therapy in $50M deal
By Nick Paul Taylor
The agreement gives Astellas first refusal for partnering on P-MUC1C-ALLO1, an allogeneic chimeric antigen receptor (CAR) T cell therapy product candidate that Poseida is developing as a treatment for solid tumors.
August 9, 2023
T Cell Social
Guardant and Illumina resolve lawsuit, reach agreement
By Nick Paul Taylor
In a statement, Guardant said the “three-year agreement includes a joint request to dismiss with prejudice the pending litigation between the companies.” The request to dismiss includes “any allegations related to the subject intellectual property.”
August 7, 2023
Business Men Handshake Social
Siemens Healthineers to distribute Scopio Labs’ full-field digital cell morphology technology
By LabPulse.com staff writers
Siemens Healthineers said the Scopio X100 and Scopio X100HT imaging platforms will complement its IVD systems, including the Atellica Hema 570 and Atellica Hema 580 analyzers.
May 8, 2023
Nanoparticle Blood Social
Werfen signs distribution agreement with Thermo Fisher for hemostasis diagnostics system
By LabPulse.com staff writers
The exclusive, long-term agreement allows Barcelona-based Werfen to continue offering the HemoCell Specialized Lab Automation system.
May 4, 2023
Business Agreement Social
Agilent Technologies, Proscia ink digital pathology distribution agreement
By LabPulse.com staff writers
Combining Agilent's pathology staining solutions with Proscia’s Concentriq Dx enterprise pathology platform will empower pathology labs to transform diagnostic efficiency and quality, Agilent said.
March 8, 2023
Concentriq Dx 2 (002)
Exact Sciences executes private placement of convertible senior notes
By LabPulse.com staff writers
Under the agreement, Exact Sciences has agreed to issue to the holder $500 million aggregate principal amount of a new series of 2% convertible senior notes due in 2030.
February 23, 2023
Hands Shaking Deal Social
Quest Diagnostics, New York-Presbyterian ink laboratory services agreement
By LabPulse.com staff writers
Their strategic objective is to broaden access to laboratory services for providers in New York, Connecticut, New Jersey, and beyond.
February 14, 2023
Women Laboratory Social
S2 Genomics, Bonsailab ink Spain, Portugal distribution agreement
By LabPulse.com staff writers
S2 Genomics is partnering with Bonsailab to promote, sell, and support its Singulator 100 and 200 systems, which provide consistent isolation of single cells or nuclei from solid-tissue samples.
January 17, 2023
Business Handshake Intelligence Social
T2 Biosystems nabs contract extension with group purchasing organization
By LabPulse.com staff writers
Products covered under the contract with Vizient, a purchasing organization for healthcare institutions, include the T2Dx Instrument, T2Bacteria Panel, and T2Candida Panel. All detect sepsis-causing bacterial and fungal pathogens from whole blood.
December 28, 2022
Hands Shaking Deal Social
Source LDPath, Ibex Medical Analytics ink agreement to deploy AI-enabled pathology platform
By LabPulse.com staff writers
AI-enabled tools will be used to diagnose multiple tissue types and improve diagnostic accuracy and efficiency, Source LDPath said.
December 7, 2022
Pathology Digital Workstation Microscope Social
Page 1 of 16
Next Page